He succeeds Dr. Uwe Brunk, who is leaving the company at his own request, according to a press release. The change is effective Feb. 1. Schneider is currently managing director of Lanxess Elastômeros do Brasil.
He succeeds Dr. Uwe Brunk, who is leaving the company at his own request, according to a press release. The change is effective Feb. 1. Schneider is currently managing director of Lanxess Elastômeros do Brasil.
Jens Birgersson becomes new Brenntag CEO
Novo Nordisk recently announced changes to its executive leadership and Board of Directors.
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Oxea is returning to its old name and its roots.